Ohad is a Partner at Pontifax, where he is in charge of scouting and project evaluation.

In his role at Pontifax, Ohad is also involved in the formation and development strategy of the fund’s early-stage portfolio companies.

He serves as a director in Agomab and Emergence Therapeutics.

BACK TO THE TEAM
client
client
client
client
client
client
client
client
client

Our board of directors is made up of seasoned industry investors and executives who provide their leadership and experience as we progress our promising pipeline into the clinic.